Factors determining constant work rate exercise tolerance in COPD and their role in dictating the minimal clinically important difference in response to interventions.
about
Muscle function, physical performance and body composition changes in men with prostate cancer undergoing androgen deprivation therapyPhysiological correlates of endurance time variability during constant-workrate cycling exercise in patients with COPD.Difference in Physiological Components of VO2 Max During Incremental and Constant Exercise Protocols for the Cardiopulmonary Exercise TestAre improvements maintained after in-home pulmonary telerehabilitation for patients with chronic obstructive pulmonary disease?Aclidinium improves exercise endurance, dyspnea, lung hyperinflation, and physical activity in patients with COPD: a randomized, placebo-controlled, crossover trial.Profile of aclidinium bromide in the treatment of chronic obstructive pulmonary diseasePeak oxygen uptake and breathing pattern in COPD patients--a four-year longitudinal studyIs exercise important in chronic obstructive pulmonary disease?Role of once-daily glycopyrronium bromide (NVA237) in the management of COPDEffectiveness of neuromuscular electrical stimulation for the rehabilitation of moderate-to-severe COPD: a meta-analysisLong-acting beta-agonists in the management of chronic obstructive pulmonary disease: current and future agents.Once-daily glycopyrronium bromide, a long-acting muscarinic antagonist, for chronic obstructive pulmonary disease: a systematic review of clinical benefit.The potential for aclidinium bromide, a new anticholinergic, in the management of chronic obstructive pulmonary disease.Aclidinium Bromide: Clinical Benefit in Patients with Moderate to Severe COPDResponsiveness of Various Exercise-Testing Protocols to Therapeutic Interventions in COPD.Exercise and COPD: therapeutic responses, disease-related outcomes, and activity-promotion strategies.Once-daily glycopyrronium bromide (Seebri Breezhaler(®)) for the treatment of chronic obstructive pulmonary disease (COPD).Greater endurance capacity and improved dyspnoea with acute oxygen supplementation in idiopathic pulmonary fibrosis patients without resting hypoxaemia.Saving Time for Patients with Moderate to Severe COPD: Endurance Test Speed Set Using Usual and Fast Walk Speeds.Combination therapy for exercise intolerance in COPD.Physiologic effects of an ambulatory ventilation system in chronic obstructive pulmonary disease.Effects of tiotropium on hyperinflation and treadmill exercise tolerance in mild to moderate chronic obstructive pulmonary disease.A randomized clinical trial investigating the efficacy of targeted nutrition as adjunct to exercise training in COPD.Home-based interval training increases endurance capacity in adults with complex congenital heart disease.Arm exercise training in chronic obstructive pulmonary disease: a randomised controlled trial.Heliox Improves Oxygen Delivery and Utilization during Dynamic Exercise in Patients with Chronic Obstructive Pulmonary Disease
P2860
Q26864943-572C5FCA-1FCB-41B2-A5BE-AAAE93C1552BQ31001836-87471B18-C323-44EB-BD5B-E4CD8DDF94E5Q34664395-79BE1047-591A-48BD-BCE0-F5674CC243EEQ35157559-F29616E7-7B76-42A2-BBAC-793FFD036AA1Q35191130-87F9CA7F-02A4-4FCD-8D5E-5519D402C84CQ35268320-CE3CAB07-91EE-4B91-85F8-A7CF6A05971BQ35749536-CA6A4865-144B-42AD-8AAD-04F14427797EQ36923011-3CB28FEF-C344-4F83-AF52-01ACDD046A48Q37120706-0D8F2D3F-D01F-4FA6-A1B9-F241A74906B0Q37468633-7440925A-5F1D-4D55-8F5B-921EC534F6F3Q37804908-6AAACABE-4688-4114-B131-04E4582F976EQ38051307-B44CA47B-A867-41FB-9AD2-DDDEBE59BF11Q38052955-62C9303C-C021-4045-85BA-651D74991F87Q38069580-EAC9C28F-75AF-4F72-9E64-8FF745EABE8AQ38083660-A59FF64F-3A92-491B-A5B0-C8E8608B07BAQ38085133-8D041018-1E76-4D02-83F1-5B40A2F3BB56Q38660895-E93E5AAE-6722-4BB7-928B-BBF947AE1C33Q38754565-C19C8812-0BF0-4106-9900-397D8FD6F9FDQ41400534-89CC94C4-E44E-46F3-8DBE-8F50CB0EEC6BQ42743964-547505C2-183C-4058-AD7D-F7ACC7BA63DCQ45910187-56BC2E9D-7F83-4EA7-BAEB-B87FFCF635ECQ46379348-501FEEBF-94FB-4DB2-B268-F8F242E8AA5FQ47103700-C4DE6EE7-BE02-487C-9D4C-95C40011E18EQ48177416-AA9CAD2D-DB4D-48F6-8417-6E96BDEA2074Q48462364-09B9B80F-7816-425C-9C7C-D39A7C802F22Q58502495-51AA626B-0160-44D3-913F-A1AF1EA78BA8
P2860
Factors determining constant work rate exercise tolerance in COPD and their role in dictating the minimal clinically important difference in response to interventions.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Factors determining constant w ...... in response to interventions.
@ast
Factors determining constant w ...... in response to interventions.
@en
type
label
Factors determining constant w ...... in response to interventions.
@ast
Factors determining constant w ...... in response to interventions.
@en
prefLabel
Factors determining constant w ...... in response to interventions.
@ast
Factors determining constant w ...... in response to interventions.
@en
P2860
P356
P1476
Factors determining constant w ...... in response to interventions.
@en
P2093
Richard Casaburi
P2860
P304
P356
10.1081/COPD-200050576
P407
P577
2005-03-01T00:00:00Z